Susan Arnold
Chief Tech/Sci/R&D Officer chez PHASEBIO PHARMACEUTICALS, INC.
Profil
Susan E.
Arnold is currently the Senior Vice President-Technical Operations at PhaseBio Pharmaceuticals, Inc. She previously worked as a Principal at AmpliPhi Biosciences Corp., AppTec Laboratory Services, Inc., and BioRexis Pharmaceutical Corp.
She also served as a Preclinical Project Manager at NuPathe, Inc. in 2013.
Dr. Arnold obtained her undergraduate degree from Holy Family University and her graduate and doctorate degrees from the University of the Sciences in Philadelphia.
Postes actifs de Susan Arnold
| Sociétés | Poste | Début |
|---|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2021 |
Anciens postes connus de Susan Arnold
| Sociétés | Poste | Fin |
|---|---|---|
AppTec Laboratory Services, Inc.
 AppTec Laboratory Services, Inc. Miscellaneous Commercial ServicesCommercial Services AppTec Laboratory Services, Inc. provides testing services to the biopharmaceutical and medical device industries. The company's services include testing, contract R&D, cGMP manufacturing, tissue-based, combination products, and cellular therapeutics. The company was founded by Bonita L. Baskin in 1989 and is headquartered in St. Paul, MN. | Corporate Officer/Principal | - |
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Corporate Officer/Principal | - |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| NUPATHE INC | Corporate Officer/Principal | - |
Formation de Susan Arnold
| Holy Family University | Undergraduate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
AppTec Laboratory Services, Inc.
AppTec Laboratory Services, Inc. Miscellaneous Commercial ServicesCommercial Services AppTec Laboratory Services, Inc. provides testing services to the biopharmaceutical and medical device industries. The company's services include testing, contract R&D, cGMP manufacturing, tissue-based, combination products, and cellular therapeutics. The company was founded by Bonita L. Baskin in 1989 and is headquartered in St. Paul, MN. | Commercial Services |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
